Critical Issues in Head and Neck Oncology

Section I :  The Make Sense Campaign.- The Make Sense Campaign.- Section II:  Head and Neck Cancer: a changing disease.- New epidemiologic aspects.- Biology of head and neck cancer.- Section III:          Diagnostic challenges.- The changing role of the pathologist.- Molecular imaging in head and neck cancer.-  Multidisciplinary Decision Making & Head and Neck Tumor Boards.-  Clinical decision making: how and when. Section V:  Locoregionally Advanced Head and Neck Cancer.- Pros and cons of endoscopic surgery.-  Oncologic dentistry and implants.- Primary radiotherapy & concurrent chemoradiotherapy.- Treatment of viral-associated head and neck cancer.- Patient and treatment factors in concurrent chemoradiotherapy.- Section VI:  Recurrent/Metastatic Head and Neck cancer: How and When to Treat.- The surgical approach.- When and how to irradiate.- Cytotoxic chemotherapy and targeted therapy.- Immunotherapeutic approaches.- Treatment in the elderly.- Supportive care.- Section VII.- Quality of life issues.- Palliative care in the palliative disease setting.- Community palliative care and dying at home.

Jan B. Vermorken graduated in 1970 from the University of Amsterdam, the Netherlands, did his internal medicine training at the University Hospital, Vrije Universiteit in Amsterdam, and became a board-certified specialist in internal medicine in 1975. Since that time he has worked in the field of Medical Oncology, initially at the Department of Internal Medicine, later at the Department of Medical Oncology of the same institute, and was officially registered as a Medical Oncologist in the Netherlands in 1992. He received his PhD in Medical Sciences in 1986 from the Vrije Universiteit in Amsterdam. From May 1997 until October 1, 2009, he was Professor of Oncology at the University of Antwerp (UA), and head of the Department of Medical Oncology at the University Hospital Antwerp (UZA), in Edegem, Belgium. After his retirement he remains connected to both University (emeritus Professor) and University Hospital. His main fields of interest are head and neck oncology and gynecologic oncology. He chaired both the Gynecologic Cancer Group (1983-1989) and the Head and Neck Cancer Group (2006-2009) of the European Organization for the Research and Treatment of Cancer (EORTC), was founding chair of the Gynecologic Cancer InterGroup (1997-2003), and stimulated the set-up of the Head and Neck Cancer International Group (HNCIG) in 2015. He devotes a large part of this time to teaching, professional training, and continuing medical education and is author or co-author of more than 650 publications.

Jean-Pascal Machiels MD, PhD, is head of department of medical oncology and a member of the directory board of the oncology center, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels Belgium. He trained at Université Catholique de Louvain, Brussels, Belgium, where he gained his MD in 1993 and his PhD in 2001 and at Johns Hopkins School of Medicine, Baltimore USA, where he was a Fellow in Medical Oncology from 1998 until 2000,. His main interests